Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing to prevent atrial fibrillation after adult cardiac surgery
ChiCTR2200064263Phase 4Not yet recruiting
- Sponsor
- Jining First People's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Atrial fibrillation (AFib) (3 arms), sponsored by Jining First People's Hospital. Primary endpoint: Incidence of postoperative atrial fibrillation. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2200064263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064263.